Apolipoprotein A1 and B as risk factors for development of intraocular metastasis in patients with breast cancer

References

• Torre LA, Bray F, Siegel R, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Karami F, Mehdipour P. A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res Int. 2013;2013(2):1–21. doi:10.1155/2013/928562
   Google Scholar
• Gray JM, Rasanayagam S, Engel C, et al. State of the evidence 2017: an update on the connection between breast cancer and the environment. Environ Health. 2017;16(1):1–61. doi:10.1186/s12940-016-0208-y28049482
   PubMedGoogle Scholar
• Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436(7050):518–524. doi:10.1038/nature0379916049480
   PubMed Web of Science ®Google Scholar
• Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3(6):537–549.12842083
   PubMed Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen T, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329–335. doi:10.1038/nature1575626524530
   PubMed Web of Science ®Google Scholar
• Bos PD, Zhang XHF, Nadal C, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009;459(7249):1005–1009. doi:10.1038/nature0802119421193
   PubMed Web of Science ®Google Scholar
• Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104(8):1265–1276.9261313
   PubMed Web of Science ®Google Scholar
• Georgalas I, Paraskevopoulos T, Koutsandrea C, et al. Ophthalmic metastasis of breast cancer and ocular side effects from breast cancer treatment and management: mini review. Biomed Res Int. 2015;2015:1–8. doi:10.1155/2015/574086
   Web of Science ®Google Scholar
• Reddy S, Kurli M, Tena LB, et al. PET/CT imaging: detection of choroidal melanoma. Brit J Ophthalmol. 2005;89(10):1265–1269. doi:10.1136/bjo.2005.06639916170113
   PubMed Web of Science ®Google Scholar
• Razek AA, Elkhamary S. MRI of retinoblastoma. Brit J Radiol. 2011;84(1005):775–784. doi:10.1259/bjr/3202249721849363
   PubMed Web of Science ®Google Scholar
• Rykun VS. Computerized ultrasonic diagnosis of voluminous intraocular neoplasms. Vestn Oftalmol. 2003;119(3):29–31.12822333
   PubMedGoogle Scholar
• Fang J, Shao Y, Su J, et al. Diagnostic value of PD-1 mRNA expression combined with breast ultrasound in breast cancer patients. Ther Clin Risk Manag. 2018;14:1527–1535. doi:10.2147/TCRM.S16853130214216
   PubMed Web of Science ®Google Scholar
• Li Y, Shao Y, Bai L, Zhou X. Increased derived neutrophil-to-lymphocyte ratio and breast imaging-reporting and data system classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy. Cancer Manag Res. 2018;10:3841–3847. doi:10.2147/CMAR.S17453730288115
   PubMed Web of Science ®Google Scholar
• Zamanian-Daryoush M, Lindner D, Tallant TC, et al. The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects. J Biol Chem. 2013;288(29):21237–21252. doi:10.1074/jbc.M113.46896723720750
   PubMed Web of Science ®Google Scholar
• Ma XL, Gao XH, Gong ZJ, et al. Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection. Oncotarget. 2016;7(43):70654–70668.27683106
   PubMedGoogle Scholar
• Sirniö P, Väyrynen JP, Klintrup K, et al. Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer. Sci Rep. 2017;7(1):1–8. doi:10.1038/s41598-016-0028-x28127051
   PubMedGoogle Scholar
• Bodai B. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. The Permanente J. 2015;19(2):48–79. doi:10.7812/TPP/14-241
   PubMedGoogle Scholar
• Anampa J, Makower D, Sparano JA. Progress in adjuvant chemotherapy for breast cancer: an overview. BMC Med. 2015;13(1):195. doi:10.1186/s12916-015-0439-826278220
   PubMedGoogle Scholar
• Puhalla S, Bhattacharya S, Davidson N E. Hormonal therapy in breast cancer: a model disease for the personalization of cancer care. Mol Oncol. 2012;6(2):222–236. doi:10.1016/j.molonc.2012.02.00322406404
   PubMed Web of Science ®Google Scholar
• Masoud V, Pagès G. Targeted therapies in breast cancer: new challenges to fight against resistance. World J Clin Oncol. 2017;8(2):120. doi:10.5306/wjco.v8.i2.12028439493
   PubMed Web of Science ®Google Scholar
• Nelson CC, Hertzberg BS, Klintworth GK, et al. A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. Am J Ophthalmol. 1983;95(6):788–793.6859188
   PubMed Web of Science ®Google Scholar
• Kreusel KM, Wiegel T, Stange M, et al. Intraocular metastases of metastatic breast carcinoma in the woman. Incidence, risk factors and therapy. Ophthalmologe. 2000;97(5):342–346.10892278
   PubMed Web of Science ®Google Scholar
• Garrett M. Ocular metastasis from seminoma. Br J Ophthalmol. 1959;43(12):759. doi:10.1136/bjo.43.12.75913826650
   PubMedGoogle Scholar
• Kelmenson AT, Grover S. Multiple bilateral ocular metastases from malignant melanoma associated with blue nevi. Eur J Ophthalmol. 2011;21(5):671–673. doi:10.5301/EJO.2011.637521360480
   PubMed Web of Science ®Google Scholar
• Niu F, Zhou Q, Yang J, et al. Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer. 2016;16(1):149. doi:10.1186/s12885-016-2169-526911831
   PubMedGoogle Scholar
• Mcdonald JW, Proia AD. Ocular metastasis as the initial presentation of esophageal carcinoma. Can J Ophthalmol. 1997;32(1):50–52.9047035
   PubMed Web of Science ®Google Scholar
• Fang KH, Chen CK, Hao SP. Acute visual loss in a head and neck cancer patient with ocular metastasis and sphenoid pyocele. Auris Nasus Larynx. 2007;34(4):569–571. doi:10.1016/j.anl.2007.02.00817490836
   PubMed Web of Science ®Google Scholar
• Sitaula R, Shrestha GB, Paudel N, Shrestha JK. Ocular and orbital metastases presenting as a first sign of gastric adenocarcinoma. BMJ Case Rep. 2011;2011(dec02 1):422–425. doi:10.1136/bcr.10.2011.4927
   Google Scholar
• Pompeu AC, Arap S, Silva MN, et al. Ocular metastasis as first presentation of renal cell carcinoma: report of 2 cases. Clinics. 2005;60(1):75–78. doi:10.1590/S1807-5932200500010001415838585
   PubMedGoogle Scholar
• Gangadharan VP, Prakash NP, Chitrathara K, Sasidharan K, Ramachandran K. Ocular metastasis of choriocarcinoma. Br J Radiol. 1999;72(864):1216–1217. doi:10.1259/bjr.72.864.1070348210703482
   PubMed Web of Science ®Google Scholar
• Khawaja MR, Minturn JT, Spittler AJ, Chiorean EG. Ocular metastasis of colorectal cancer: an uncommon presentation of a common malignancy. Hematol Oncol Stem Cell Ther. 2015;8(4):176–180. doi:10.1016/j.hemonc.2015.02.00225784129
   PubMedGoogle Scholar
• Weers PMM, Patel AB, Wan LC, et al. Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation. J Lipid Res. 2010;52(1):35–44. doi:10.1194/jlr.M00750020884842
   PubMed Web of Science ®Google Scholar
• Nyunt AK, Ishida Y, Yu Y, Shimada S. Topical apolipoprotein A-1 may have a beneficial effect on the corneal epithelium in a mouse model of dry eye: a pilot study. Eye Contact Lens. 2008;34(5):287–292. doi:10.1097/ICL.0b013e318184bdb618779669
   PubMed Web of Science ®Google Scholar
• Kawai S, Nakajima T, Hokari S, Komoda T, Kawai K. Apolipoprotein A-I concentration in tears in diabetic retinopathy. Ann Clin Biochem. 2002;39(Pt 1):56–61. doi:10.1258/000456302190174811853190
   PubMed Web of Science ®Google Scholar
• Buch H, Vinding T, La Cour M, Jensen GB, Prause JU, Nielsen NV. Risk factors for age-related maculopathy in a 14-year follow-up study: the copenhagen city eye study. Acta Ophthalmol Scand. 2005;83(4):409–418. doi:10.1111/j.1600-0420.2005.00492.x16029262
   PubMedGoogle Scholar
• Ma M, Yuan S, Chen Y, Zhou Z-W. Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer. Oncotargets Ther. 2018;11:2169–2176. doi:10.2147/OTT
   PubMed Web of Science ®Google Scholar
• Clarke CH, Yip C, Badgwell D, et al. Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer. Gynecol Oncol. 2011;122(3):548–553. doi:10.1016/j.ygyno.2011.06.00221708402
   PubMed Web of Science ®Google Scholar
• Liu Z, Xiao Y, Tang L, et al. Apolipoprotein A1-75 G/A and +83 C/T polymorphisms and renal cancer risk. Lipids in Health Dis. 2015;14(1):1–6. doi:10.1186/s12944-015-0132-0
   PubMedGoogle Scholar
• His M, Zelek L, Deschasaux M, et al. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol. 2014;29(2):119–132. doi:10.1007/s10654-014-9884-524519551
   PubMed Web of Science ®Google Scholar
• Lane DM, Boatman KK, Mcconathy WJ. Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res Tr. 1995;34(2):161–169. doi:10.1007/BF00665788
   PubMed Web of Science ®Google Scholar
• Martin LJ, Melnichouk O, Huszti E, et al. Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points. J Natl Cancer I. 2015;107(5):djv032. doi:10.1093/jnci/djv032
   PubMedGoogle Scholar
• Yu Q, Zhang Y, Xu CB. Apolipoprotein B, the villain in the drama? Eur J Pharmacol. 2015;748:166–169. doi:10.1016/j.ejphar.2014.08.03725218904
   PubMed Web of Science ®Google Scholar
• Son JH, Chung YK, Son JS. Apolipoprotein B: novel indicator of elevated intraocular pressure. Eye. 2015;29(10):1315–1320. doi:10.1038/eye.2015.3725853444
   PubMed Web of Science ®Google Scholar
• Modrzejewska A. Relationship between initial lens transparency and ocular circulation in adolescents with Type-1 diabetes mellitus, unstable glycaemia and lipid parameters. Polish Journal of Radiology. 2014;79(1):472–478. doi:10.12659/PJR.89085225535511
   PubMedGoogle Scholar
• Kinnunen K, Heinonen SE, Kalesnykas G, et al. LDLR-/-ApoB100/100 mice with insulin-like growth factor II overexpression reveal a novel form of retinopathy with photoreceptor atrophy and altered morphology of the retina. Mol Vis. 2013;19(19):1723–1733.23922490
   PubMedGoogle Scholar
• Sacca SC, Centofanti M, Izzotti A. New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor. Invest Ophthalmol Vis Sci. 2012;53(7):4242–4253. doi:10.1167/iovs.11-890222618596
   PubMed Web of Science ®Google Scholar
• Blanc V, Davidson NO. C-to-U RNA editing. Mechanisms leading to genetic diversity. J Biol Chem. 2003;278(3):1395–1398. doi:10.1074/jbc.R20002420012446660
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Marusawa H, Kinoshita K, et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 2007;13(4):470–476. doi:10.1038/nm156617401375
   PubMed Web of Science ®Google Scholar
• Henderson S, Chakravarthy A, Su X, et al. APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. Cell Rep. 2014;7(6):1833–1841. doi:10.1016/j.celrep.2014.05.01224910434
   PubMed Web of Science ®Google Scholar
• Yu Y, Cai W, Pei CG, et al. Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy. Biochem Bioph Res Co. 2015;458(4):913–919. doi:10.1016/j.bbrc.2015.02.059
   PubMed Web of Science ®Google Scholar
• Yu Y, Yu J, Pei CG, et al. Xanthatin, a novel potent inhibitor of VEGFR2 signaling, inhibits angiogenesis and tumor growth in breast cancer cells. Int J Clin Exp Pathol. 2015;8(9):10355–10364.26617743
   PubMed Web of Science ®Google Scholar